The systemic cardiovascular complications of cirrhosis include generalized vasodilatation manifested clinically as hypotension, decreased systemic vascular resistance, increased cardiac output and an increased rate of blood flow through the tissues (1-4); it is commonly called the hyperdynamic circu
Nitric oxide: The elusive mediator of the hyperdynamic circulation of cirrhosis?
β Scribed by Dr. Brendan J. R. Whittle; Salvador Moncada
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 560 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
For more than a decade it has been known that the vascular endothelium releases a labile factor involved in the relaxation of smooth muscle when stimulated by a variety of vasodilator substances such as acetylcholine (1,2). The identity of this mediator, known originally as endothelium-derived relaxing factor, remained elusive until 1987, when it was demonstrated that nitric oxide gas (NO) had biological properties identical to those of endothelium-derived relaxing factor and that it is released from endothelial cells in quantities sufficient to explain its actions (3). These findings were independently confirmed by other groups (4, 5).
The next phase in the biological history of this simple "inorganic" molecule was the finding that the amino acid L-arginine is the substrate for the enzyme NO synthase. This enzyme generates NO from the terminal guanidino nitrogen atoms of L-arginine (6) through a process in which molecular oxygen is also incorporated (7). The identification of L-arginine analogs such as NG-monomethyl-L-arginine (L-NMMA) as specific inhibitors of NO biosynthesis (8, 9) was a crucial step in understanding this biochemical pathway.
With the availability of these NO synthase inhibitors, the biological sigmfmnce of this elementary molecule could be more fully appreciated. Thus early in uiuo experiments in the rabbit and rat ( 1 0 , l l ) demonstrated that the systemic hypotensive action of acetylcholine could be attenuated by L-NMMA administration; this supported findings obtained using isolated vascular tissue (8, 9). Of fundamental importance was the realization that endogenous NO has a profound influence on the cardiovascular system because L-NMMA substantially elevates systemic arterial blood pressure (10-12). The specificity of these effects of L-NMh4.A was demonstrated by the failure of its enantiomer D-NMMA to exert such cardiovascular actions, and the actions of L-NMMA were abolished by concurrent administration of L-arginine but not D-arginine. Studies in human subjects confirmed the importance of NO in the regulation of vascular tone because infusion of L-NMMA into the brachial artery caused vasoconstriction and attenuated the vasodilatation induced by acetylcholine (13).
Further studies in uiuo established a role for endogenous NO in the regulation of blood flow in the gastric mucosa and splanchnic circulation (14,15
π SIMILAR VOLUMES
Chronic bile duct ligation is associated with the development of oxidant injury, biliary cirrhosis, portal hypertension, and a hyperdynamic circulation. We have previously demonstrated that the hyperdynamic circulation in the partial portal vein-ligated rat can be prevented by the administration of
An increased release of nitric oxide (NO), a powerful vasodilating agent, has been proposed to play a role in the pathogenesis of vasodilation and hyperdynamic circulation associated with advanced cirrhosis. We evaluated NO synthase (NOS) activity in peripheral leukocytes of 12 cirrhotic patients an
Humoral factors may be responsible for the hyperdynamic circulation seen in portal hypertension. Endotoxin, a peripheral arteriolar vasodilator, has been proposed to mediate this hernodynamic picture. We examined the pathogenic role of endotoxin in portal vein-ligated rats, a prehepatic portal hyper
## **The hyperdynamic circulatory syndrome observed in chronic liver diseases is a great example of research that originated from clinical observations and progressed in the last 50 years from the patient to the experimental laboratory. Our knowledge has evolved from the patient to the molecule, u